Literature DB >> 12736090

Screening of the early growth response 2 gene in Japanese patients with Charcot-Marie-Tooth disease type 1.

Chikahiko Numakura1, Emi Shirahata, Sumimasa Yamashita, Masayo Kanai, Kazuki Kijima, Takasumi Matsuki, Kiyoshi Hayasaka.   

Abstract

Charcot-Marie-Tooth disease type 1 (CMT1) is a heterogeneous disorder. Most CMT1 patients are associated with a duplication of 17p11.2-p12 (CMT1A duplication), but a small number of patients have mutations of peripheral myelin protein 22 (PMP22), myelin protein zero (MPZ), connexin 32 (Cx32) and early growth response 2 (EGR2) genes. In our previous study, we identified the responsible mutations in 72 of 128 Japanese CMT1 patients as CMT1A duplication in 40, PMP22 mutation in 6, MPZ mutation in 12 and Cx32 mutation in 14 patients. A total of 56 Japanese CMT1 patients with no identified mutations were screened for EGR2 mutation by denaturing gradient gel electrophoresis (DGGE). We detected a heterozygous Asp383Tyr mutation of EGR2 in one patient with severe CMT1, Dejerine-Sottas syndrome. EGR2 mutation is rare cause of CMT1 in Japan as in other nations. We were unable to identify the responsible mutation in 55 of 128 CMT1 patients and need further analysis to identify their candidate genes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12736090     DOI: 10.1016/s0022-510x(03)00028-5

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  8 in total

Review 1.  Autosomal-recessive forms of demyelinating Charcot-Marie-Tooth disease.

Authors:  O Dubourg; H Azzedine; C Verny; G Durosier; N Birouk; R Gouider; M Salih; A Bouhouche; A Thiam; D Grid; M Mayer; M Ruberg; M Tazir; A Brice; E LeGuern
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

Review 2.  Molecular genetics of autosomal-dominant demyelinating Charcot-Marie-Tooth disease.

Authors:  Henry Houlden; Mary M Reilly
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

3.  An algorithm for genetic testing of Serbian patients with demyelinating Charcot-Marie-Tooth.

Authors:  Milica P Keckarevic Markovic; Jelena Dackovic; Jelena Mladenovic; Vedrana Milic-Rasic; Miljana Kecmanovic; Dusan Keckarevic; Stanka Romac
Journal:  Genet Test Mol Biomarkers       Date:  2012-11-19

4.  Functional, histopathologic and natural history study of neuropathy associated with EGR2 mutations.

Authors:  Kinga Szigeti; Wojciech Wiszniewski; Gulam Mustafa Saifi; Diane L Sherman; Norbert Sule; Adekunle M Adesina; Pedro Mancias; Sozos Ch Papasozomenos; Geoffrey Miller; Laura Keppen; Donna Daentl; Peter J Brophy; James R Lupski
Journal:  Neurogenetics       Date:  2007-08-24       Impact factor: 2.660

5.  Periaxin mutation causes early-onset but slow-progressive Charcot-Marie-Tooth disease.

Authors:  Kazuki Kijima; Chikahiko Numakura; Emi Shirahata; Yukio Sawaishi; Mitsuteru Shimohata; Shuichi Igarashi; Tomohiro Tanaka; Kiyoshi Hayasaka
Journal:  J Hum Genet       Date:  2004-06-12       Impact factor: 3.172

6.  Mitochondrial GTPase mitofusin 2 mutation in Charcot-Marie-Tooth neuropathy type 2A.

Authors:  Kazuki Kijima; Chikahiko Numakura; Hiroko Izumino; Kazuo Umetsu; Atsuo Nezu; Toshihide Shiiki; Masafumi Ogawa; Yoshito Ishizaki; Takeshi Kitamura; Yasunobu Shozawa; Kiyoshi Hayasaka
Journal:  Hum Genet       Date:  2004-11-11       Impact factor: 4.132

Review 7.  New evidence for secondary axonal degeneration in demyelinating neuropathies.

Authors:  Kathryn R Moss; Taylor S Bopp; Anna E Johnson; Ahmet Höke
Journal:  Neurosci Lett       Date:  2020-12-24       Impact factor: 3.046

8.  A de novo EGR2 variant, c.1232A > G p.Asp411Gly, causes severe early-onset Charcot-Marie-Tooth Neuropathy Type 3 (Dejerine-Sottas Neuropathy).

Authors:  Bianca R Grosz; Natasha B Golovchenko; Melina Ellis; Kishore Kumar; Garth A Nicholson; Anthony Antonellis; Marina L Kennerson
Journal:  Sci Rep       Date:  2019-12-18       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.